InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Mily Elizabeth, Vice-Président Exécutif, Stratégie et Développement Commercial. Insider active across 2 companies, notably Bristol Myers Squibb Co. In total, 7 filings have been published. History available since 10 March 2022. The latest transaction was filed on 30 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Mily Elizabeth is Executive Vice President, Strategy and Business Development. She has 7 filings in total, with recent filings spanning 2022-03-14 to 2026-05-01, involving Bristol Myers Squibb Co and Solventum Corp. The stated total buy and sell amounts for these recent filings are EUR 0 each, and the most frequent transaction nature is Option exercise.